Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Why "Safely" Depends on Which Device You Have The label lists multi-dose pens in three configurations 2 mg/3 mL for four doses of 0.25 mg and two doses of 0.5 mg or four doses of 0.5 mg, 4 mg/3 mL for four doses of 1 mg, and 8 mg/3 mL for four doses of 2 mg each supplied with NovoFine Plus needles
American Diabetes Association 2026 Scientific Sessions
Seek immediate medical attention (call 999 or go to A&E) if you experience: Severe hypoglycaemia with confusion, loss of consciousness, seizures, or inability to treat yourself Severe, persistent abdominal pain that may radiate to the back (possible pancreatitis) Signs of diabetic ketoacidosis : excessive thirst, frequent urination, nausea, vomiting, abdominal pain, fruity-smelling breath, confusion, or difficulty breathing Severe allergic reaction (anaphylaxis): difficulty breathing, swelling of face or throat, rapid pulse, severe rash Contact your GP or diabetes team within 24 hours if you notice: Recurrent hypoglycaemia (more than 23 episodes per week of blood glucose below 4 mmol/L) Persistent hyperglycaemia (blood glucose consistently above 15 mmol/L despite medication adherence) Severe or persistent gastrointestinal symptoms preventing adequate food or fluid intake Signs of dehydration : decreased urination, dizziness, dry mouth, particularly with vomiting or diarrhoea Unexplained weight loss despite good glycaemic control Persistent injection site reactions or signs of infection New visual symptoms (possible retinopathy changes) Right upper abdominal pain, fever, or jaundice (possible gallbladder disease) Schedule a routine review if: You're planning pregnancy or have become pregnant (dulaglutide is not recommended in pregnancy
Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity
NUTREND is the market leader in sports nutrition products and food for active lifestyles
: , : ' - , L-
